Zhejiang Haichuangda Biomaterials Co., Ltd. announced a private placement of common stock to returning investor Zhejiang Hisun Biomaterials Co., Ltd. for gross proceeds of CNY 750,861,163.68 on September 20, 2022. The transaction has been approved at 22nd meeting of the 6th board of directors and the 23rd meeting of the 6th board of supervisors and still pending approval from the company's shareholders.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
8.49 CNY | +2.66% |
|
-3.19% | -34.79% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-34.79% | 231M | |
+21.18% | 68.87B | |
-5.01% | 46.12B | |
+24.57% | 44.85B | |
+32.63% | 27.9B | |
+8.44% | 19.38B | |
+16.07% | 17.2B | |
-12.24% | 14.68B | |
-29.11% | 14.14B | |
+21.71% | 11.33B |
- Stock Market
- Equities
- 688203 Stock
- News Zhejiang Hisun Biomaterials Co.Ltd.
- Zhejiang Haichuangda Biomaterials Co., Ltd. announced that it expects to receive CNY 750.861163 million in funding from Zhejiang Hisun Biomaterials Co.Ltd.